Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
11.15
+0.97 (9.53%)
At close: Jun 27, 2025, 4:00 PM
11.20
+0.05 (0.45%)
After-hours: Jun 27, 2025, 7:59 PM EDT
Capricor Therapeutics Stock Forecast
Stock Price Forecast
According to 8 professional analysts, the 12-month price target for Capricor Therapeutics stock ranges from a low of $21 to a high of $77. The average analyst price target of $33.75 forecasts a 202.69% increase in the stock price over the next year.
Price Target: $33.75 (+202.69%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Capricor Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
---|---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 | 5 |
Buy | 3 | 3 | 3 | 3 | 3 | 3 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 7 | 7 | 7 | 7 | 7 | 8 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
B. Riley Securities | B. Riley Securities | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +88.34% | Jun 26, 2025 |
Jones Trading | Jones Trading | Strong Buy Maintains $40 → $29 | Strong Buy | Maintains | $40 → $29 | +160.09% | Jun 25, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $77 | Strong Buy | Reiterates | $77 | +590.58% | Jun 24, 2025 |
Oppenheimer | Oppenheimer | Buy Maintains $43 → $22 | Buy | Maintains | $43 → $22 | +97.31% | Jun 23, 2025 |
Roth Capital | Roth Capital | Strong Buy Reiterates $31 | Strong Buy | Reiterates | $31 | +178.03% | Jun 17, 2025 |
Financial Forecast
Revenue This Year
79.94M
from 22.27M
Increased by 258.96%
Revenue Next Year
86.36M
from 79.94M
Increased by 8.02%
EPS This Year
-0.42
from -1.15
EPS Next Year
-0.43
from -0.42
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 244.1M | 190.6M | 275.4M | ||
Avg | 79.9M | 86.4M | 180.0M | ||
Low | 5.9M | 25.4M | 66.2M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 996.2% | 138.4% | 218.9% | ||
Avg | 259.0% | 8.0% | 108.5% | ||
Low | -73.6% | -68.2% | -23.4% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 1.80 | 1.28 | 2.09 | ||
Avg | -0.42 | -0.43 | 1.21 | ||
Low | -1.87 | -1.33 | -0.48 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.